Company news
Crinetics Pharmaceuticals, Inc. news in 2020
Crinetics Pharmaceuticals, Inc.'s news releases, calls and decks from 2020, newest first.
Crinetics Pharmaceuticals to Participate in December Investor Conferences
November 22, 2020
Crinetics Pharmaceuticals Appoints Acromegaly Expert, Peter Trainer, Vice President of Clinical Endocrinology
November 15, 2020
Crinetics Hosting Key Opinion Leader Meeting Focusing on Oral Paltusotine for the Treatment of Acromegaly
November 12, 2020
Crinetics Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
November 5, 2020
Crinetics Pharmaceuticals Announces Phase 2 ACROBAT Edge Study with Paltusotine in Acromegaly Met Primary Endpoint
October 25, 2020
Crinetics Pharmaceuticals Receives Rare Pediatric Disease Designation from FDA for CRN04777 for the Treatment of Congenital Hyperinsulinism
September 20, 2020
Crinetics Pharmaceuticals Provides New Data from Paltusotine and ACTH Antagonist Development Programs at European Congress of Endocrinology
September 3, 2020
Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of Directors
September 2, 2020
Crinetics Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
August 6, 2020
Crinetics Pharmaceuticals Receives Orphan Drug Designation for Paltusotine for the Treatment of Acromegaly
July 7, 2020
Crinetics Pharmaceuticals Confirms Completion for Half of the Enrolled Patients in the Ongoing Phase 2 ACROBAT Edge Clinical Trial for Paltusotine
June 10, 2020
Crinetics Pharmaceuticals Appoints Adriana Cabré, MBA, as Vice President of Human Resources
May 26, 2020
Crinetics Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 7, 2020
Crinetics Pharmaceuticals Reports Positive Interim Results for the ACROBAT Edge Phase 2 Trial of Paltusotine (CRN00808) in Acromegaly Patients and Provides Corporate Update
April 5, 2020
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
March 8, 2020
Decks in 2020
- Technical Presentation (November 2020)
Technical · 58 slides · Nov 20, 2020
- Technical Presentation (October 2020)
Technical · 27 slides · Oct 26, 2020
- Corporate Update (April 2020)
Corporate update · 9 slides · Apr 6, 2020